![Пакет изследвания за жената /CA 19-9, , СА 125 r.r PSA, и СЕА общ туморен маркер/, от Медикодиагностична лаборатория "Д-р Тошкина" Пакет изследвания за жената /CA 19-9, , СА 125 r.r PSA, и СЕА общ туморен маркер/, от Медикодиагностична лаборатория "Д-р Тошкина"](https://www.omed.bg/images/cache/product/4143_large.jpg)
Пакет изследвания за жената /CA 19-9, , СА 125 r.r PSA, и СЕА общ туморен маркер/, от Медикодиагностична лаборатория "Д-р Тошкина"
![The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line](https://www.jcancer.org/v09/p4255/jcav09p4255g001.jpg)
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig3_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-1292-1-PB.jpg)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-17175-7/MediaObjects/41598_2017_17175_Fig1_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Пакет изследвания за жената /CA 19-9, СА 15-3, СА 125 и СЕА общ туморен маркер/, само за 50 лв от Медикодиагностична лаборатория "Д-р Ноневи" Пакет изследвания за жената /CA 19-9, СА 15-3, СА 125 и СЕА общ туморен маркер/, само за 50 лв от Медикодиагностична лаборатория "Д-р Ноневи"](https://www.omed.bg/images/cache/product/4055_large.jpg)
Пакет изследвания за жената /CA 19-9, СА 15-3, СА 125 и СЕА общ туморен маркер/, само за 50 лв от Медикодиагностична лаборатория "Д-р Ноневи"
![Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1743919113010789-gr1.jpg)
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
![Пакет изследвания на туморни маркери за мъже - PSA, CA 19-9 и CEA, от Медико-диагностична лаборатория Лина | Grabo Mobile Пакет изследвания на туморни маркери за мъже - PSA, CA 19-9 и CEA, от Медико-диагностична лаборатория Лина | Grabo Mobile](https://imgrabo.com/pics/deals/15081468126202.jpeg)
Пакет изследвания на туморни маркери за мъже - PSA, CA 19-9 и CEA, от Медико-диагностична лаборатория Лина | Grabo Mobile
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig2_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Fast detection of tumor marker CA 19-9 using AlGaN/GaN high electron mobility transistors - ScienceDirect Fast detection of tumor marker CA 19-9 using AlGaN/GaN high electron mobility transistors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0925400518306968-gr3.jpg)
Fast detection of tumor marker CA 19-9 using AlGaN/GaN high electron mobility transistors - ScienceDirect
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitnxjed-32.jpg)